ArticleBMC medical imaging2025
Zero-echo time magnetic resonance imaging for visualizing pulmonary neoplasms.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulmonary surveillance in inborn errors of immunity: current challenges and emerging approaches.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo assess the ability of a zero-echo time sequence combined with a highly flexible adaptive image receiving coil (AIRTM coil) to visualize pulmonary neoplasms.
methodsA total of 42 patients with pulmonary neoplasms were included, all of whom underwent chest CT and MRI examinations. A highly flexible AIRTM coil was used. The MR-ZTE and CT images were compared in terms of subjective and objective image quality.
resultsIntrapulmonary structures were imaged using MRI-ZTE. Various nodules and masses, including micronodules, subsolid or ground glass opacification nodules, and various masses, were clearly visualized via MRI-ZTE. In terms of subjective image quality, there was no significant difference in lesion detectability between CT and MRI-ZTE (P = 0.8). In terms of objective image quality for MRI-ZTE, the SNRs and CNRs of the lung parenchyma, pulmonary nodules, trachea, peripheral bronchus, and peripheral pulmonary vessels were good.
conclusionsMRI-ZTE enabled the detection of intrapulmonary structures and various pulmonary neoplasms with good image quality, including micronodules, subsolid or ground glass opacification nodules, and various masses. Therefore, MRI-ZTE has great potential as a nonradiation alternative to CT for the follow-up of pulmonary neoplasms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.